Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation.
Lesly CalderónKarina SchindlerStephen G MalinAlexandra SchebestaQiong SunTanja SchwickertChiara AlbertiMaria FischerMarkus JaritzHiromi TagohAnja EbertMartina MinnichAdrian ListonLuisa CochellaMeinrad BusslingerPublished in: Science immunology (2022)
The transcription factor Pax5 controls B cell development, but its role in mature B cells is largely enigmatic. Here, we demonstrated that the loss of Pax5 by conditional mutagenesis in peripheral B lymphocytes led to the strong reduction of B-1a, marginal zone (MZ), and germinal center (GC) B cells as well as plasma cells. Follicular (FO) B cells tolerated the loss of Pax5 but had a shortened half-life. The Pax5-deficient FO B cells failed to proliferate upon B cell receptor or Toll-like receptor stimulation due to impaired PI3K-AKT signaling, which was caused by increased expression of PTEN, a negative regulator of the PI3K pathway. Pax5 restrained PTEN protein expression at the posttranscriptional level, likely involving Pten-targeting microRNAs. Additional PTEN loss in Pten,Pax5 double-mutant mice rescued FO B cell numbers and the development of MZ B cells but did not restore GC B cell formation. Hence, the posttranscriptional down-regulation of PTEN expression is an important function of Pax5 that facilitates the differentiation and survival of mature B cells, thereby promoting humoral immunity.
Keyphrases
- pi k akt
- cell cycle arrest
- cell proliferation
- signaling pathway
- toll like receptor
- transcription factor
- induced apoptosis
- immune response
- poor prognosis
- inflammatory response
- nuclear factor
- crispr cas
- high resolution
- adipose tissue
- drug delivery
- oxidative stress
- peripheral blood
- insulin resistance
- cell death
- metabolic syndrome
- skeletal muscle
- long non coding rna